FDA-approved branded GLP-1 medications Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, Trulicity, Victoza are the finished drug products that ran the SUSTAIN, STEP, and SURMOUNT clinical trials
Stopping semaglutide early also reduces the risk of side effects, such as nausea or vomiting, which could interfere with the IVF process
For musculoskeletal use, it is commonly considered for tendon irritation, ligament sprains, muscle strains, fascia-related pain, overuse injuries, and joint-adjacent soft-tissue pain
Because GLP-1 receptors in the hypothalamus and brainstem respond quickly to circulating drug, many people describe reduced hunger, earlier satiety, smaller portion sizes, and a decline in food-related cravings or "food noise." These subjective effects can appear even while measurable weight change remains modest